Phase II Clinical Trial for Prevention of Delayed Diarrhea with Cholestyramine/Levofloxacin in the Second-Line Treatment with Irinotecan Biweekly in Patients with Metastatic Colorectal Carcinoma

Publisher： Karger

E-ISSN： 1423-0232|72|1-2|10-16

ISSN： 0030-2414

Source： Oncology, Vol.72, Iss.1-2, 2007-11, pp. : 10-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Randomised Phase II Study of Irinotecan in Combination with 5-FU/FA Compared with Irinotecan Alone as Second-Line Treatment of Patients with Metastatic Colorectal Carcinoma

By  

Oncology Research and Treatment, Vol. 30, Iss. 4, 2007-03 ,pp. : 169-174

Karger

Access to resources Recommend Favorite

Phase II Trial of Chemotherapy plus Bevacizumab as Second-Line Therapy for Patients with Metastatic Colorectal Cancer That Progressed on Bevacizumab with Chemotherapy: The Gunma Clinical Oncology Group (GCOG) trial 001 SILK Study

By  

Oncology, Vol. 83, Iss. 3, 2012-08 ,pp. : 151-157

Karger

Access to resources Recommend Favorite

Second-Line Treatment of Advanced Colorectal Cancer with a Biweekly Oxaliplatin plus Irinotecan Combination Regimen

By  

Oncology Research and Treatment, Vol. 25, Iss. 4, 2002-09 ,pp. : 358-362

Karger

Access to resources Recommend Favorite

Irinotecan in Second-Line Therapy of Metastatic Colorectal Cancer

By  

Oncology Research and Treatment, Vol. 23, Iss. 4, 2000-05 ,pp. : 15-17

Karger

Access to resources Recommend Favorite

Phase II Trial of Navelbine and Fluorouracil as Second-Line Chemotherapy in Metastatic Breast Carcinoma

By  

Oncology, Vol. 55, Iss. 1, 1997-12 ,pp. : 87-88

Karger

Access to resources Recommend Favorite